Efficacy study to evaluate denosumab compared to placebo in preventing microstructural bone decay in premenopausal women receiving total oestradiol depletion therapy for early breast cancer
Latest Information Update: 05 Jun 2019
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Sep 2016 Status changed from not yet recruiting to recruiting.
- 09 Aug 2016 New trial record